Why the treatment with Reprimun could be efficient for tuberculosis prevention in HIV infected individuals.
Păunescu
E
E
Marius Nasta Institute of Pneumophthisiology, Depart. of Immunochemistry and Radioisotopes, Bucharest.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D004341:Drug Evaluation; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012294:Rifamycins / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*
D007166:Immunosuppressive Agents; D012294:Rifamycins; C062637:Reprimun